Podcasts about pgy

Welcome back to our series on AI for the clinician! Large language models, like ChatGPT, have been taking the world by storm, and healthcare is no exception to that rule – your institution may already be using them! In this episode we'll tackle the fundamentals of how they work and their applications and limitations to keep you up to date on this fast-moving, exciting technology. Hosts: Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  Phillip Jenkins, MD: @PhilJenkinsMD Phil Jenkins is a general surgery PGY-3 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics. Steven Bedrick, PhD: @stevenbedrick Steven Bedrick is a machine learning researcher and an Associate Professor in Oregon Health and Science University's Department of Medical Informatics and Clinical Epidemiology. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Welcome to our new series – the AI Journal Club! In this series, we'll cover some interesting studies and evidence-based applications of artificial intelligence in surgery in a case-based format. Surely AI can find a DVT by now … or can it? Stay tuned and find out! Hosts: - Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. - Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  - Marisa Sewell, MD: @MarisaSewell Marisa Sewell is a general surgery PGY-4 at Oregon Health and Science University.  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, welcomes Aamir Hussain, MD, to discuss high-yield strategies for dermatology exam prep. They start with a board review on contact dermatitis, covering key allergens like paraphenylenediamine, methylisothiazolinone and methylchloroisothiazolinone, propylene glycol, and bacitracin. Dr Hussain shares a structured approach to studying allergens, including memorizing the last 5 years of "Allergen of the Year" and the T.R.U.E. TEST's 36 most common allergens. They then break down exam timelines and study strategies, using insights from Dr Hussain's recent publication. from the BASIC exam in PGY-2 to the 4 CORE board exams in PGY-3. They share tips on prioritizing sections and using the best textbooks, atlases, question banks, and digital tools, as well as touch on the value of in-person and virtual review courses and how to maximize free resident resources. Tune in to the episode for high-yield pearls and a structured approach to acing your dermatology exams!

Lorlatinib is reshaping first-line treatment for ALK-positive NSCLC—but its distinct side effect profile demands proactive, personalized management. In this episode,  Stefanie Houseknecht, PharmD, BCOP (Johns Hopkins Medicine) and Monica Chintapenta, PharmD, BCOP (Parkland Health)share how they're navigating real-world use of lorlatinib, from interpreting long-term data to counseling patients through CNS effects, weight gain, and metabolic challenges.Highlights:Why lorlatinib is gaining traction in first-line ALK+ NSCLCWhat the long-term CROWN data really means for patient outcomesHow to handle tricky side effects like cognitive changes, weight gain, and hyperlipidemiaReal-world tips for patient counseling and supporting adherenceThe importance of catching drug interactions and staying ahead on labsHow pharmacists are shaping care across the oncology teamBonus: Hear how our guests find balance beyond the clinic, whether in the garden or on the Boston marathon course. About Our Guests:Monica completed her Doctor of Pharmacy at Texas Tech University Health Sciences Center and went on to complete PGY-1 and PGY-2 residencies at Tufts Medical Center and Froedtert & the Medical College of Wisconsin, respectively. At Parkland, she supports outpatient hematology/oncology care and leads quality initiatives.   Stefanie earned her PharmD from the University of the Pacific, followed by PGY-1 and PGY-2 residencies at Palomar Medical Center and the University of California-San Diego. Her work focuses on thoracic malignancies, access to oral targeted therapies, and patient outcomes. She is active in the International Association for the Study of Lung Cancer and serves as a preceptor to pharmacy trainees across the Mid-Atlantic.  

Dr. Patimavirujh, A PGY-2 resident at the USF Morsani College of Medicine, reviews the use of steroid medication in the management of infectious diseases syndromes. Following an introduction on the history of steroids in medicine, the speaker compares and contrasts steroid agents with mineralcorticoid and glucocorticoid activity. Next, the pharmacokinetics of steroids are discussed, as well as dose equivalencies for the different steroid molecules. Next, the use of steroids for various infectious diseases are discussed, including for pneumonia (including Pneumocystis infection), bacterial meningitis, TB meningitis, and cryptococcal meningitis.

Dr. Michael Colello, who passed the 2024 ABOS Part I Examination, provides tips on how he was successful and what residents of any PGY)should do now to set themselves up for success. In addition. Dr. Colello discusses his current fellowship and what residents should think about when considering a fellowship.

Navigating EM residency can be tricky and often difficult. EMRA*Cast host Nishant Gogna, DO, presents a group discussion navigating the tips, tricks, and pitfalls to watch out for in your EM residency, with Joanne Bethencourt, DO, PGY-3 and chief resident at UF Health Shands Hospital; Mario Hernandez, MD, PGY-3 at UF Health Shands Hospital; and Wade Chen, MD, PGY-3 at UF Health Shands Hospital. 

Show notes at pharmacyjoe.com/episode1017. In this episode, I'll discuss 10 tips for providing effective feedback to PGY-1 residents. The post 1017: Tips for providing effective feedback to PGY-1 residents appeared first on Pharmacy Joe.

In this episode, we talk to Dr. Ryan Ottwell, a PGY-4 at Trinity Health Dermatology Residency, about creating a strong ERAS application. Drawing from his experiences, Dr. Ottwell breaks down key components - from cover letters and letters of recommendation to hobbies - offering tips on how applicants can highlight their unique stories. Having successfully guided several medical students to match, he hopes these insights will help others navigate the process and is eager to continue mentoring students along the way. We hope you enjoy!If you enjoyed this episode, please share it with other students interested in dermatology!Dr. Ryan OttwellInstagram: @⁠ryan_ottwell⁠---DIGA: @⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠derminterest⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Today's Host: Marissa Ruppe @marissamarieruppe ---For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠---Music: "District Four" Kevin MacLeod (⁠⁠⁠⁠⁠incompetech.com⁠⁠⁠⁠⁠) Licensed under Creative Commons: By Attribution 4.0 License: ⁠⁠⁠⁠⁠http://creativecommons.org/licenses/by/4.0

Dr. Alec Yu is a PGY-4 resident doing his Rheumatology subspecialty training at the University of British Columbia in Vancouver. He has a particular interest in inner city health.

Reference: Pessano S, et al. Positioning for lumbar puncture in newborn infants. Cochrane Database Syst Rev. December 2023 Date: February 7, 2025 Guest Skeptic: Dr. Lauren Rosenfeld is a PGY-3 emergency medicine resident at George Washington University. She is also a new podcast host for Emergency Medicine Residents' Association (EMRA) Cast Series. Case: A five-day-old […] The post SGEM #470: Here We Go Up Up Up or Lateral for Infant Lumbar Punctures first appeared on The Skeptics Guide to Emergency Medicine.

The Vascular Surgery Subspecialty Team dives into the pressing issue of burnout among vascular surgery trainees. Unveiling surprising statistics and expert insights, they explore the alarming prevalence of burnout, its causes like work-home conflict and physical discomfort, and the protective role of mentorship and a supportive learning environment. With research-backed discussions, they navigate strategies to combat burnout and enhance the well-being of medical professionals. Hosts:  Dr. Bobby Beaulieu is an Assistant Professor of Vascular Surgery at the University of Michigan and the Program Director of the Integrated Vascular Surgery Residency Program as well as the Vascular Surgery Fellowship Program at the University of Michigan. Dr. Frank Davis is an Assistant Professor of Vascular Surgery at the University of Michigan Dr. Drew Braet is a PGY-5 Integrated Vascular Surgery Resident at the University of Michigan Learning Objectives -  Review the definition and prevalence of burnout - Understand the risk factors, including both modifiable and non-modifiable risk factors, for burnout  - Review the effects of burnout on trainees and attending surgeons References 1.    Hekman KE, Sullivan BP, Bronsert M, Chang KZ, Reed A, Velazquez-Ramirez G, Wohlauer MV; Association of Program Directors in Vascular Surgery Issues Committee. Modifiable risk factors for burnout in vascular surgery trainees. J Vasc Surg. 2021 Jun;73(6):2155-2163.e3. doi: 10.1016/j.jvs.2020.12.064. https://pubmed.ncbi.nlm.nih.gov/33675887/ 2.    Cui CL, Reilly MA, Pillado EB, Li RD, Eng JS, Grafmuller LE, DiLosa KL, Conway AM, Escobar GA, Shaw PM, Hu YY, Bilimoria KY, Sheahan MG 3rd, Coleman DM. Burnout is not associated with trainee performance on the Vascular Surgery In-Training Exam. J Vasc Surg. 2025 Jan;81(1):243-249.e4. doi: 10.1016/j.jvs.2024.08.057. https://pubmed.ncbi.nlm.nih.gov/39233022/ 3.    Chia MC, Hu YY, Li RD, Cheung EO, Eng JS, Zhan T, Sheahan MG 3rd, Bilimoria KY, Coleman DM. Prevalence and risk factors for burnout in U.S. vascular surgery trainees. J Vasc Surg. 2022 Jan;75(1):308-315.e4. doi: 10.1016/j.jvs.2021.06.476.  https://pubmed.ncbi.nlm.nih.gov/34298120/ 4.    Davila VJ, Meltzer AJ, Hallbeck MS, Stone WM, Money SR. Physical discomfort, professional satisfaction, and burnout in vascular surgeons. J Vasc Surg. 2019 Sep;70(3):913-920.e2. doi: 10.1016/j.jvs.2018.11.026.  https://pubmed.ncbi.nlm.nih.gov/31279532/ 5.    Pillado E, Li RD, Chia MC, Eng JS, DiLosa K, Grafmuller L, Conway A, Escobar GA, Shaw P, Sheahan MG 3rd, Bilimoria KY, Hu YY, Coleman DM. Reported pain at work is a risk factor for vascular surgery trainee burnout. J Vasc Surg. 2024 May;79(5):1217-1223. doi: 10.1016/j.jvs.2024.01.003.  https://pubmed.ncbi.nlm.nih.gov/38215953/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Do you find yourself saying: “Hey, what's the big idea with that newfangled whole blood in the refrigerator next to the trauma bay?”  Like using whole blood but not sure why?  Don't like using whole blood but not sure why? Join us for a 30 minute power session in whole blood where we try to get you the information you need to know! Hosts: - Michael Cobler-Lichter, MD, PGY4/R2: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @mdcobler (X/twitter) - Eva Urrechaga, MD, PGY-8, Vascular Surgery Fellow University of Pennsylvania Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center General Surgery Residency @urrechisme (X/twitter) - Eugenia Kwon, MD, Trauma/Surgical Critical Care Attending: Loma Linda University  Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center Trauma/CC Fellowship - Jonathan Meizoso, MD, MSPH Assistant Professor of Surgery, 6 years in practice University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @jpmeizoso (twitter) Learning Objectives: - Describe the proposed benefits of whole blood resuscitation in trauma -  Identify current problems with synthesizing the existing literature on whole blood resuscitation in trauma - Propose needed areas for future research regarding whole blood resuscitation in trauma Quick Hits: 1. There is significant heterogeneity in study design across whole blood resuscitation studies, complicating comparison 2.  There is likely a mortality benefit to whole blood resuscitation in trauma, however this is likely dependent on the specific population 3. Future research directions should focus on prospective randomized work to try and better quantify the exact benefit of whole blood, and determine in which populations this benefit is actually realized References 1.     Hazelton JP, Ssentongo AE, Oh JS, Ssentongo P, Seamon MJ, Byrne JP, Armento IG, Jenkins DH, Braverman MA, Mentzer C, Leonard GC, Perea LL, Docherty CK, Dunn JA, Smoot B, Martin MJ, Badiee J, Luis AJ, Murray JL, Noorbakhsh MR, Babowice JE, Mains C, Madayag RM, Kaafarani HMA, Mokhtari AK, Moore SA, Madden K, Tanner A 2nd, Redmond D, Millia DJ, Brandolino A, Nguyen U, Chinchilli V, Armen SB, Porter JM. Use of Cold-Stored Whole Blood is Associated With Improved Mortality in Hemostatic Resuscitation of Major Bleeding: A Multicenter Study. Ann Surg. 2022 Oct 1;276(4):579-588. doi: 10.1097/SLA.0000000000005603. Epub 2022 Jul 18. PMID: 35848743. https://pubmed.ncbi.nlm.nih.gov/35848743/ 2.     Sperry JL, Cotton BA, Luther JF, Cannon JW, Schreiber MA, Moore EE, Namias N, Minei JP, Wisniewski SR, Guyette FX; Shock, Whole Blood, and Assessment of Traumatic Brain Injury (SWAT) Study Group. Whole Blood Resuscitation and Association with Survival in Injured Patients with an Elevated Probability of Mortality. J Am Coll Surg. 2023 Aug 1;237(2):206-219. doi: 10.1097/XCS.0000000000000708. Epub 2023 Apr 11. PMID: 37039365; PMCID: PMC10344433. https://pubmed.ncbi.nlm.nih.gov/37039365/ 3.     Meizoso JP, Cotton BA, Lawless RA, et al. Whole blood resuscitation for injured patients requiring transfusion: A systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2024;97(3):460-470. doi:10.1097/TA.0000000000004327 https://pubmed.ncbi.nlm.nih.gov/38531812/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Join the Behind the Knife Surgical Oncology Team as we discuss the presentation, work-up, and management of neuroendocrine tumors of the small bowel. Learning Objectives: In this episode, we review the basics of neuroendocrine (NE) tumors of the small bowel, including how to evaluate patients with presenting symptoms consistent with NE tumors, initial work-up, staging, and management.  We discuss key concepts including DOTATATE scans and medical therapies high yield for direct patient care and board exams.  Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles. Connor Chick, MD (@connor_chick) is a 2nd Year Surgical Oncology fellow at Ohio State University. Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 1st Year Surgical Oncology fellow at MD Anderson. Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center Links to Paper Referenced in this Episode: Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. PMID: 28076709; PMCID: PMC5895095. https://pubmed.ncbi.nlm.nih.gov/28076709/ ***SPECIALTY TEAM APPLICATION LINK: https://docs.google.com/forms/d/e/1FAIpQLSdX2a_zsiyaz-NwxKuUUa5cUFolWhOw3945ZRFoRcJR1wjZ4w/viewform?usp=sharing Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.

In this episode, we talk to Dr. Valerie Foy, a PGY-2 at St. John's Episcopal Dermatology Residency, about her path to dermatology. Dr. Foy shares about her experiences in medical school including the challenges of not matching her fourth year. With determination and resilience, she made the most of her transitional year, ultimately securing a spot at her dream dermatology program. Throughout our conversation, Dr. Foy's warmth, openness, and enthusiasm is clear to hear. We hope you enjoy!If you enjoyed this episode, please share it with other students interested in dermatology!Dr. Valerie Foy instagram: @derm.dr.val---DIGA: @⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠derminterest⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Today's Host: Marissa Ruppe---For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠---Music: District Four by Kevin MacLeodLink: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://incompetech.filmmusic.io/song/3662-district-four⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠License: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/sta

In this episode, we talk with Dr. Kelly Kimball, MD. Dr. Kimball is a current PGY-2 at the OhioHealth Riverside Methodist Hospital program. Dr. Kimball has made research a strong point in her CV from applying to medical school, summer research programs, and ultimately applying to residency. She has continued this research fervor into residency as well! Come and hear her thoughts on the types of research, its importance, and her current work. Also, if you are interested in learning more about the dermatology residency program that Dr. Kimball is in go check out DIGA episode #91! We hope you enjoy!   If you enjoyed this episode, please share it with other students interested in dermatology!   Learn More: Educational links: - How to Conduct a Systematic Review - Publish free with Cureus Website: https://www.ohiohealth.com/medical-education/residencies/dermatology-riverside-methodist Instagram: @medicineandmakeupwithkelly X: kellymkimball   --- DIGA Instagram: @derminterest Today's Host, George: @georgepapadeas --- For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com --- District Four by Kevin MacLeod Link: **https://incompetech.filmmusic.io/song/3662-district-four** License: **https://filmmusic.io/standard-license** --- Send in a voice message: https://podcasters.spotify.com/pod/show/derminterest/message

Up next for our curriculum series is an episode on Nephrology! Take a listen so that you're prepared for our pre-test! Authors: Dr. Lara Melo Soares Pinho de Carvalho, PGY-3, and Dr. Ritika Kompella, Chief Medical Resident, UCONN  Host: Dr. Ritika Kompella, Chief Medical Resident, UCONN  Guest speakers:  Acute kidney injury in liver failure: Dr. Ruchir Trivedi, Associate Professor of Medicine, Department of Nephrology Paraproteinemia and Amyloidosis- Dr. Srimathi Manickaratnam, Department of Nephrology  Hyponatremia: Dr. Lalarukh Haider, Department of Nephrology

0.0 - “Love Works” with Oyinemi “Yemi” Iyebote (Medical Student - Howard University) 10.14 - “To Control” with Dr. Blessed Sheriff (Psychiatry Resident at Georgetown U) 17.24 - “The Vines” with Jessica Ray (Medical Student at Howard U) 20.40 - “Of Fear & Self-Doubt” with Jessica Brinson (Medical Student at Howard U) 26.18 - “That Hurt” with Dr. Lane Williams, PGY-2 Internal Medicine Resident (WRNMMC) 37.42 - “& Poison” with Bryce Gantt (Medical Student - Howard University) 44.46 - “The Garden” with Trinity Gibbs (Medical Student - Howard University)   Works Cited: Intro Music: Bosch's Garden - by Kjartan Abel. This work is licensed under the following: CC BY-SA 4.0 Attribution-ShareAlike 4.0 International.

CancerNetwork® spoke with Natasha Bahri, MD, MS, and Daneng Li, MD, about their Hot Topics article titled Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?, which was published in the November 2024 issue of ONCOLOGY®. Their article focused on findings related to the use of 177Lutetium-Dotatate (177Lu-dotatate; Lutathera) in patients with neuroendocrine tumors (NETs) and whether these data supported the use of the novel radioligand therapy for this population. Bahri is a PGY-5 chief fellow in Medical Oncology and Hematology at City of Hope National Medical Center in Duarte, California. Li is an associate professor in the Department of Medical Oncology & Therapeutics Research at City of Hope Comprehensive Cancer Center in Duarte, California, and a gastrointestinal editorial board member of ONCOLOGY. Bahri and Li discussed findings from the phase 3 NETTER-1 trial (NCT01578239) assessing 177Lu-dotatate for those with inoperable, locally advanced or metastatic, grade 1/2 midgut NETs following progression on long-acting repeatable octreotide therapy. Although these findings established a significant efficacy signal with the radioligand therapy, Li noted that questions remained regarding the sequencing of 177Lu-dotatate alongside other therapies in the treatment landscape. The conversation also covered efficacy, safety, and quality-of-life (QOL) data from the phase 3 NETTER-2 trial (NCT03972488), in which investigators assessed high-dose octreotide with or without 177Lu-dotatate among patients with locally advanced or metastatic, well-differentiated, somatostatin receptor–positive gastroenteropancreatic NETs. Although data showed improvements in efficacy with the 177Lu-dotatate combination, there did not appear to be significant differences regarding QOL outcomes between arms. “We're waiting for further long-term follow-up information as there was no difference in the QOL metrics. It's important to think about how these patients' goals align with the therapy that we're giving, and if we're not seeing a difference in the quality of life quite yet, [we need to] look at individual patients, see what their goals are, and match them up to the therapy that we're giving them,” Bahri stated. Although the NETTER-1 and NETTER-2 trials demonstrate “great” results associated with efficacy end points such as progression-free survival, the authors noted that it is crucial to weigh these benefits with the potential toxicities when determining suitable candidates for treatment with 177Lu-dotatate. “There's a lot of nuances in terms of who is the ideal patient that's going to maximally benefit [while] minimizing any risk of serious toxicity in those patients. As a result of that, we're helping to improve their outcomes to the highest bars possible, whether it's quality of life or survival,” Li concluded. References 1.        Strosberg J, El-Haddad G, Wolin E, et al; NETTER-1 Trial Investigators. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125-135. doi:10.1056/NEJMoa1607427 2.        Singh S, Halperin D, Myrehaug S, et al; NETTER-2 Trial Investigators. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. Lancet. 2024;403(10446):2807-2817. doi:10.1016/S0140-6736(24)00701-3

Send us a textWelcome back to the Neurophilia Podcast! Today's episode is a continuation of our "Neurology in Residency" series. We cover the third year of neurology residency, commonly known as PGY-3 year. We discussed the PGY-3 structure and expectations of this clinical year across various residency programs. Our guests shared incredible stories from this year of training, highlighting areas of growth and inner turmoil. Make sure you listen to the full episode!Guests:Dr. Weige (Charlie) Zhao is a fourth-year neurology resident at Mass General Brigham in Boston, MA. Dr. Marinos Sotiropolous is a fourth-year neurology resident at Mass General Brigham in Boston, MA. Dr. Stephanie Reyes is a fourth-year neurology resident at Duke Neurology in Durham, NC.Dr. Aakash Patel is a fourth-year neurology resident at UPMC in Pittsburgh, PA.Dr, Price Tipping is a fourth-year neurology resident at Cleveland Clinic in Cleveland, OH.   Hosts:Dr. Nupur Goel is a second-year neurology resident at Mass General Brigham in Boston, MA. Follow Dr. Nupur Goel on Twitter @mdgoelsDr. Blake Buletko is a vascular neurologist and program director of the Adult Neurology Residency Program at the Cleveland Clinic in Cleveland, OH. Follow Dr.  Blake Buletko on Twitter @blakebuletkoFollow the Neurophilia Podcast on Twitter and Instagram @NeurophiliaPodSupport the show

In this episode, we talk with PGY-3 Dr. John Tsatalis a current resident at the University of Miami dermatology program. Dr. Tsatalis gives a rundown on timeless dermatology history, tells us about his path into dermatology, various aspects of the University of Miami program, and his general day-to-day as a part of one of the largest dermatology programs in the country! We hope you enjoy!   If you enjoyed this episode, please share it with other students interested in dermatology! Learn More: Website: https://med.miami.edu/departments/dermatology/education/residency-program --- DIGA Instagram: @derminterest Today's Host, George: @georgepapadeas --- For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com --- District Four by Kevin MacLeod Link: **https://incompetech.filmmusic.io/song/3662-district-four** License: **https://filmmusic.io/standard-license** --- Send in a voice message: https://podcasters.spotify.com/pod/show/derminterest/message

Kennedy Dunn, 4th year medical student at Howard U & Dr. Lane Williams, PGY-2 Internal Medicine Resident, WRNMMC navigate pain, bruises and what it means to be human in the fifth episode of Stranger Fruit Vol III. Timestamps: 0:00 Introduction and Navigating Emotional Challenges 9:18 Life Transitions and Personal Growth 22:22 Investing in Yourself and Embracing Discipline 34:13 Empathy and Relationships in Medicine 42:32 Managing Emotions and Decision-Making References:  Harper, D. (n.d.). Hurt. In Online Etymology Dictionary. Retrieved from https://www.etymonline.com Lamm, C., & Decety, J. (2007). Empathy for pain involves the affective but not sensory components of pain. Science, 315(5811), 1257-1262. https://doi.org/10.1126/science.1134473  

A 67 year old woman with a history of hypertension, hyperlipidemia, diabetes, and a 25 pack year smoking history is referred your clinic and is referred for evaluation of her peripheral arterial disease. She reports pain with walking that has limited her doing some daily activities. How can you optimally manage this patient? Does she need an operation? In this episode, we will cover the basics of peripheral arterial disease, discuss the specifics of optimal medical management and dive into the nuances of when (or if) you should offer these patients an operation.  Hosts:  Dr. Bobby Beaulieu is an Assistant Professor of Vascular Surgery at the University of Michigan and the Program Director of the Integrated Vascular Surgery Residency Program as well as the Vascular Surgery Fellowship Program at the University of Michigan. Dr. Drew Braet is a PGY-5 Integrated Vascular Surgery Resident at the University of Michigan Learning Objectives - Review the definition, prevalence, and risk factors for peripheral arterial disease - Understand the specifics of optimal medical management of patients with peripheral arterial disease  - Discuss the controversy regarding operative management of patients with claudication and review indications for an operation in patients with peripheral arterial disease - Review the appropriate anti-platelet and anti-coagulation strategies after interventions in patients with peripheral arterial disease References 1.    Woo K, Siracuse JJ, Klingbeil K, Kraiss LW, Osborne NH, Singh N, Tan TW, Arya S, Banerjee S, Bonaca MP, Brothers T, Conte MS, Dawson DL, Erben Y, Lerner BM, Lin JC, Mills JL Sr, Mittleider D, Nair DG, O'Banion LA, Patterson RB, Scheidt MJ, Simons JP; Society for Vascular Surgery Appropriateness Committee. Society for Vascular Surgery appropriate use criteria for management of intermittent claudication. J Vasc Surg. 2022 Jul;76(1):3-22.e1. doi: 10.1016/j.jvs.2022.04.012. Epub 2022 Apr 22. PMID: 35470016. https://pubmed.ncbi.nlm.nih.gov/35470016/ 2.    Nordanstig J, Behrendt CA, Baumgartner I, Belch J, Bäck M, Fitridge R, Hinchliffe R, Lejay A, Mills JL, Rother U, Sigvant B, Spanos K, Szeberin Z, van de Water W; ESVS Guidelines Committee; Antoniou GA, Björck M, Gonçalves FB, Coscas R, Dias NV, Van Herzeele I, Lepidi S, Mees BME, Resch TA, Ricco JB, Trimarchi S, Twine CP, Tulamo R, Wanhainen A; Document Reviewers; Boyle JR, Brodmann M, Dardik A, Dick F, Goëffic Y, Holden A, Kakkos SK, Kolh P, McDermott MM. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg. 2024 Jan;67(1):9-96. doi: 10.1016/j.ejvs.2023.08.067. Epub 2023 Nov 10. PMID: 37949800. https://pubmed.ncbi.nlm.nih.gov/37949800/ 3.    Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TSD, Gutiérrez JA, Hawkins BM, Hess CN, Ho KJ, Jones WS, Kim ESH, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, Pollak AW, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, Wilkins LR. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jun 11;149(24):e1313-e1410. doi: 10.1161/CIR.0000000000001251. Epub 2024 May 14. PMID: 38743805. https://pubmed.ncbi.nlm.nih.gov/38743805/ 4.    Belch JJ, Dormandy J; CASPAR Writing Committee; Biasi GM, Cairols M, Diehm C, Eikelboom B, Golledge J, Jawien A, Lepäntalo M, Norgren L, Hiatt WR, Becquemin JP, Bergqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010 Oct;52(4):825-33, 833.e1-2. doi: 10.1016/j.jvs.2010.04.027. Epub 2010 Aug 1. Erratum in: J Vasc Surg. 2011 Feb;53(2):564. Biasi, B M [corrected to Biasi, G M]. PMID: 20678878. https://pubmed.ncbi.nlm.nih.gov/20678878/ 5.    Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27. PMID: 28844192. https://pubmed.ncbi.nlm.nih.gov/28844192/ 6.    Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, Fanelli F, Capell WH, Diao L, Jaeger N, Hess CN, Pap AF, Kittelson JM, Gudz I, Mátyás L, Krievins DK, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR. Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med. 2020 May 21;382(21):1994-2004. doi: 10.1056/NEJMoa2000052. Epub 2020 Mar 28. PMID: 32222135. https://pubmed.ncbi.nlm.nih.gov/32222135/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode of Audible Bleeding, editor Dr. Imani McElroy (@IEMcElroy) is joined by General Surgery PGY-4 Sasank Kalipatnapu(@ksasank) along with Dr.David Rigberg, MD (@drigberg), and Dr. Guillermo Escobar, MD (@GAEscobarMD) to discuss the Society for Clinical Vascular Surgery (SCVS) Rising Seniors / Incoming Fellows Program. This episode brings out a conversation exploring the history behind the development of the program, the current state of the program, and the overwhelming importance of the program in the current day. The episode also provides a broad overview of the content presented in the program and the reasoning behind the talks.    Guests: Dr. David Rigberg - Professor of Surgery, Division of Vascular and Endovascular Surgery, Gonda Vascular Center, Program Director for the Vascular fellowship and integrated vascular surgery residency at the David Geffen School of Medicine, UCLA, Los Angeles, California Dr. Guillermo Escobar- Associate Professor, Division of Vascular Surgery and Endovascular Therapy, Program Director for the Vascular Surgery Fellowship and Residency at Emory University School of Medicine   Relevant links: Rising Seniors / Incoming Fellows Program - Program Details SCVS - Fellows & Chief Residents Program SCVS - Young Vascular Surgeons Program   To apply for the Rising Seniors / Incoming Fellows Program, go to apply now! Audible Bleeding team: Dr. Imani McElroy is 1st year vascular surgery fellow at USC/LA and editor at Audible Bleeding Dr. Sasank Kalipatnapu, PGY-4 general surgery resident, Dept of Surgery, UMass Chan Medical School, Worcester, MA Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

Today we spoke with Dr. Michael Fritz, MD. Dr. Fritz is a PGY-3 at the Indiana University dermatology residency program in Indianapolis, Indiana. Dr. Fritz gives us a candid conversation talking about his path finding dermatology as well as aspects about the IU program. Listen in to hear more! If you enjoyed this episode, please share it with other students interested in dermatology!   Learn More: Website: https://medicine.iu.edu/dermatology/education/residency --- DIGA Instagram: @derminterest Today's Host, George: @georgepapadeas --- For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com --- District Four by Kevin MacLeod Link: **https://incompetech.filmmusic.io/song/3662-district-four** License: **https://filmmusic.io/standard-license** --- Send in a voice message: https://podcasters.spotify.com/pod/show/derminterest/message

Episode 150. I round out this series with tips for the medical residency match process by going over the important general considerations about choosing your program regardless of your specialty, from the point of view of a PGY-2 resident physician. This includes things to remember while interviewing and planning your rank list. I also discuss specific considerations for psychiatry and family medicine programs and questions I recommend asking as an osteopathic applicant. Editing Service for Pre-Med and Medical Students (CV, personal statement, applications):⁠ ⁠https://www.fiverr.com/firstlinepod⁠⁠  Visit First Line's website and blog:⁠ ⁠⁠⁠https://poddcaststudios.wixsite.com/firstlinepodcast⁠⁠ For a discount off your TrueLearn subscription use link:⁠ ⁠https://truelearn.referralrock.com/l/firstline/⁠⁠ and code: firstline Instagram: @firstlinepodcast Facebook:⁠ ⁠www.facebook.com/firstlinepodcast⁠⁠ Email: firstlinepodcast@yahoo.com Content on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.

Episode 149. Hear from a PGY-2 about the two reasons why you would want to send letters of interest. I also discuss what an LOI should include and some best practices that I recommend. LOI and Other Editing Service for Pre-Med and Medical Students (CV, personal statement, applications): ⁠https://www.fiverr.com/firstlinepod⁠  Visit First Line's website and blog: ⁠https://poddcaststudios.wixsite.com/firstlinepodcast⁠ For a discount off your TrueLearn subscription use link: ⁠https://truelearn.referralrock.com/l/firstline/⁠ and code: firstline Instagram: @firstlinepodcast Facebook: ⁠www.facebook.com/firstlinepodcast⁠ Email: firstlinepodcast@yahoo.com Content on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.

In this podcast, various residency program directors, coordinators, and residents from across the state share some unique aspects of their PGY-1 ambulatory care residency experiences. Listen in to hear more about the following programs:Aurora Health Care Metro Inc. PGY-1 Community-Based Pharmacy Residency – Amy Mahlum, PharmD, BCACP (RPD)Concordia University of Wisconsin PGY-1 Pharmacy Practice Residency – Sarah Ray, PharmD, BCPS, FAPhA (RPD)Froedtert & the Medical College of Wisconsin PGY-1 Pharmacy Residency (Ambulatory Care Setting) – Teresa Mysliwiec, PharmD, BCACP, AAHIVP (RPD) and Kaitlin Mockus, PharmD, BCACP (RPC)SSM Health - Monroe Clinic PGY-1 Pharmacy Practice Residency – Julie Bartell, PharmD, BCACP, FPSW (RPD) and Alison DeVore, PharmD (current PGY-1 resident)Tomah VA Medical Center PGY-1 Pharmacy Practice Residency – Kristin Arndt, PharmD, BCPS (RPD)William S. Middleton Memorial Veterans Hospital PGY-1 Pharmacy Residencies in Ambulatory Care, General Practice, and HSPAL – Maria Wopat, PharmD, BCACP (RPD)UW Health PGY-1 Pharmacy Practice Residency – Becca Ninos, PharmD,  BCACP (PGY-1 Preceptor and PGY-2 Ambulatory Care RPC)

In this podcast, various residency program directors and residents from across the state share some unique aspects of their PGY-2 ambulatory care residency experiences. Listen in to hear more about the following programs:Aurora Health Care Metro, Inc. PGY-2 Ambulatory Care Pharmacy Residency – Jennifer Foti, PharmD, BCACP (RPD)Froedtert & MCW PGY-2 Ambulatory Care Residency – Jonathan White, PharmD, BCACP (RPD)Froedtert & MCW PGY-2 Thrombosis and Hemostasis Management Residency – Mikie Te Ronde, PharmD (RPD) and Julia Kluck, PharmD (current PGY-2 resident)Mayo Clinic Health System – Eau Claire Hospital, Inc. PGY-2 Ambulatory Care Residency – Katie Taylor, PharmD, BCACP (RPD)SSM Health – Monroe Clinic PGY-2 Ambulatory Care Residency – Julie Bartell, PharmD, BCACP (RPD) and Kelly Thomas, PharmD (current PGY-2 resident)UW-Health PGY-2 Ambulatory Care Residency – Kristina Heimerl, PharmD, BCACP (RPD)

Dr. Joshua Brady and Dr. Daniel Hyman, both PGY-4's at the University of Oklahoma Dermatology Residency Program, share the strengths of their program. They also shared information about the Oklahoma City area and their path to dermatology. Today's Host, Mark: @markyduboisconley --- For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ --- Music: District Four by Kevin MacLeod Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://incompetech.filmmusic.io/song/3662-district-four⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ License: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/standard-license

In this episode, we review key components of the landmark MAGIC and FLOT-4 trials that investigated perioperative chemotherapy in the treatment of locally advanced gastric cancer.  We discuss limitations of both trials and the evolving clinical landscape of gastric cancer treatment. Hosts: - Timothy Vreeland, MD, FACS (@vreelant) is an Associate Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist/HPB surgeon at Brooke Army Medical Center. - Daniel Nelson, DO, FACS (@usarmydoc24) is a Surgical Oncologist/HPB surgeon at Kaiser Permanente Los Angeles Medical Center. - Connor Chick, MD (@connor_chick) is a Surgical Oncology Senior Fellow at Ohio State. - Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology Junior Fellow at MD Anderson Cancer Center. - Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center.  Learning Objectives:  1.     Understand background, methodology, results, and interpretation of the MAGIC trial. 2.     Understand background, methodology, results, and interpretation of the FLOT trial. 3.     Be able to discuss the evolution of chemotherapeutic regimens in the treatment of locally advanced gastric cancer and rationale for their use. 4.     Be able to describe key limitations for the above regimens. 5.     Discuss the the evolving clinical landscape for chemotherapy in gastroesophageal junction tumors. Links to Papers Referenced in this Episode: Journal Articles: Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J., Nicolson, M., ... & Chua, Y. J. (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine, 355(1), 11-20. https://pubmed.ncbi.nlm.nih.gov/16822992/ Al-Batran, S. E., Homann, N., Pauligk, C., Goetze, T. O., Meiler, J., Kasper, S., ... & Hofheinz, R. D. (2019). Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. The Lancet, 393(10184), 1948-1957. https://pubmed.ncbi.nlm.nih.gov/30982686/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Dr. Paarth Dodia, a PGY-4, shares his experience at the Sampson RMC Residency Program in North Carolina. He also shares his path into dermatology. Today's Host, Mark: @markyduboisconley --- For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ --- Music: District Four by Kevin MacLeod Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://incompetech.filmmusic.io/song/3662-district-four⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ License: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/standard-license

Episode 147. As a PGY-2, I speak on the two types of questions that can be asked during residency program interviews and specific examples of questions to ask to program directors, residents, and faculty members. Editing Service for Pre-Med and Medical Students (CV, personal statement, applications): ⁠https://www.fiverr.com/firstlinepod⁠  Visit First Line's website and blog: ⁠https://poddcaststudios.wixsite.com/firstlinepodcast⁠ For a discount off your TrueLearn subscription use link: ⁠https://truelearn.referralrock.com/l/firstline/⁠ and code: firstline Instagram: @firstlinepodcast Facebook: ⁠www.facebook.com/firstlinepodcast⁠ Email: firstlinepodcast@yahoo.com Content on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.

Dr. Alexis Coican, a PGY-2 at Orange Park Dermatology, shares her experience of reapplying during her transitional year. She gives advice to those who are unmatched and shares strategies and options for those reapplying. Today's Host, Mark: @markyduboisconley --- For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ --- Music: District Four by Kevin MacLeod Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://incompetech.filmmusic.io/song/3662-district-four⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ License: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/standard-license

Send us a textWelcome back to the Neurophilia Podcast! We are joined by four neurology residents to discuss the first two years of residency training. Stay tuned to listen to our conversation regarding PGY-2 year! Guests:Adnan Husein, MD is a PGY3 resident at UCLA in Los Angeles, CA. Follow him on Twitter: @AdnanHuseinMD.Katherine Bruch, MD is a PGY2 resident at Mass General Brigham in Boston, MA.Ashley Audi, MD is a PGY2 resident at Cleveland Clinic in Cleveland, OH. Follow her on Twitter: @ashleyaudi22Sakhi Bhansali, MD is a PGY3 resident at Cleveland Clinic in Cleveland, OH. Follow her on Twitter: @DrSakhiiOur Hosts:Dr. Nupur Goel is a second-year neurology resident at Mass General Brigham in Boston, MA. Follow Dr.  Nupur Goel on Twitter @mdgoelsDr. Blake Buletko is a vascular neurologist and program director of the Adult Neurology Residency Program at the Cleveland Clinic in Cleveland, OH. Follow Dr.  Blake Buletko on Twitter @blakebuletkoFollow the Neurophilia Podcast on Twitter and Instagram @NeurophiliaPodSupport the show

Up next for our curriculum series is an episode on Pulmonology! Take a listen so that you're prepared for our pre-test! Author: Dr. Akshita Sahi, PGY-3, UCONN  Host and Editor: Dr. Ritika Kompella, Chief Medical Resident, UCONN Guest speakers: Pulmonary Hypertension: Dr. Jose Soriano, Assistant Professor of Medicine Diffuse parenchymal disease: Dr. Ameer Rasheed, Assistant Professor of Medicine (*correction 8:03: secondary pulmonary lobule, instead of nodule) Pleural disease and pulmonary nodules: Dr. Omar Ibrahim, Associate Professor of Medicine, Director, Interventional Pulmonary Additional resources: https://www.ahajournals.org/doi/10.1161/JAHA.122.029024 https://pubmed.ncbi.nlm.nih.gov/35412560/

Connection Kennedy Dunn, 3rd year medical student at Howard U and Dwayne Thomas, PGY-1 Surgery Resident at Naval Medical Center San Diego discuss connection and what it means to be human in the 4th episode of Stranger Fruit Vol II.   Timestamps: 0:00 The Essence of Choices and Life's Connections 4:45 Psychiatry Insights and Professional Networking 12:56 Growth, Mentorship, and the Power of Connection 37:26 Embracing Change and Personal Development 55:08 Reflections on Grief, Self-Discovery, and Conclusion   Works Cited:  Intro Music: Bosch's Garden - by Kjartan Abel. This work is licensed under the following: CC BY-SA 4.0 Attribution-ShareAlike 4.0 International.

Welcome to the second episode of our citation classics series on adult reconstruction. In this episode, we talk about the highest cited articles over the last 20 years thereabout on the topic, 'THA Approaches'. Enjoy! Meet our adult reconstruction citation classics team! We have Dr. Sohum Patel, a PGY-5 resident at Indiana University Medical Center; Hassan Farooq, who is a PGY-3 resident at Loyola University Health System; Nigel Blackwood, a research fellow at University of Alabama; and we also have Kaihui Zhu, a 4th year medical student at Washington State University. This episode is sponsored by the American Academy of Orthopaedic Surgeons: Filled with content that has been vetted by some of the top names in orthopaedics, the AAOS Resident Orthopaedic Core Knowledge (ROCK) program sets the standard for orthopaedic education. Whether ROCK is incorporated into your residency curriculum, or you use it independently as a study tool, the educational content on ROCK is always free to residents. You'll gain the insights and confidence needed to ensure a successful future as a board-certified surgeon who delivers the best patient care. Log on at https://rock.aaos.org/.

Send us a textWelcome back to the Neurophilia Podcast! We are joined by four neurology residents to discuss the first two years of residency training. Stay tuned to listen to our conversation regarding intern or PGY-1 year! Guests:Adnan Husein, MD is a PGY3 resident at UCLA in Los Angeles, CA. Follow him on Twitter: @AdnanHuseinMD.Katherine Bruch, MD is a PGY2 resident at Mass General Brigham in Boston, MA.Ashley Audi, MD is a PGY2 resident at Cleveland Clinic in Cleveland, OH. Follow her on Twitter: @ashleyaudi22Sakhi Bhansali, MD is a PGY3 resident at Cleveland Clinic in Cleveland, OH. Follow her on Twitter: @DrSakhiiOur Hosts:Dr. Nupur Goel is a second-year neurology resident at Mass General Brigham in Boston, MA. Follow Dr.  Nupur Goel on Twitter @mdgoelsDr. Blake Buletko is a vascular neurologist and program director of the Adult Neurology Residency Program at the Cleveland Clinic in Cleveland, OH. Follow Dr.  Blake Buletko on Twitter @blakebuletkoFollow the Neurophilia Podcast on Twitter and Instagram @NeurophiliaPodSupport the show

A NEW SEASON means new grades! Bryan and Kristen also announce some free giveaways for the season, look back at what worked and what didn't in season two, add some instant KILLs to the running tally, announce some of the new theme months and answer your listener questions.

Have you ever been confused about the concept of brain death, or struggled to explain brain death to a patient's family or your fellow clinicians? Join the Behind the Knife Surgical Palliative Care team and our special guest, neurologist & neurointensivist Dr. Sarah Wahlster, as we explore the 2023 Pediatric & Adult Brain Death/Death by Neurologic Criteria Consensus Practice Guideline and what this updated guideline means for our practice in surgical palliative care! Hosts: Dr. Katie O'Connell (@katmo15) is an Associate Professor of Surgery at the University of Washington in the division of Trauma, Burn, and Critical Care Surgery. She is a trauma surgeon, palliative care physician, Director of Surgical Palliative Care, and founder of the Advance Care Planning for Surgery Clinic at Harborview Medical Center in Seattle, WA. Dr. Virginia Wang is a PGY-3 General Surgery resident at the University of Washington. Guest: Dr. Sarah Wahlster (@SWahlster) is an Associate Professor of Neurology at the University of Washington. She is a neurologist, neurointensivist, and Program Director of the Neurocritical Care Fellowship at Harborview Medical Center in Seattle, WA. Learning Objectives: ·      Understand the concept of assent and how it can be helpful in communicating with families of patients who have sustained brain death ·      Explain the main steps required for diagnosis of brain death (prerequisites, clinical exam, apnea testing, ancillary testing) ·      Understand key differences between the 2023 guideline and previous (2010 & 2011) guidelines ·      Be able to name the 3 accepted modalities of ancillary testing for brain death ·      Know basic communication best practices with families of patients who have sustained brain death from the surgical palliative care perspective (consistency of language & messaging; avoidance of phrases such as “life-sustaining treatment”, “comfort-focused measures”) References: 1.     Greer, D. M., Kirschen, M. P., Lewis, A., Gronseth, G. S., Rae-Grant, A., Ashwal, S., Babu, M. A., Bauer, D. F., Billinghurst, L., Corey, A., Partap, S., Rubin, M. A., Shutter, L., Takahashi, C., Tasker, R. C., Varelas, P. N., Wijdicks, E., Bennett, A., Wessels, S. R., & Halperin, J. J. (2023). Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline. Neurology, 101(24), 1112–1132. https://doi.org/10.1212/WNL.0000000000207740 2.     Lewis, A., Kirschen, M. P., & Greer, D. (2023). The 2023 AAN/AAP/CNS/SCCM Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Practice Guideline: A Comparison With the 2010 and 2011 Guidelines. Neurology. Clinical practice, 13(6), e200189. https://doi.org/10.1212/CPJ.0000000000200189 3.     AAN Interactive Brain Death/Death by Neurologic Criteria Evaluation Tool – https://www.aan.com/Guidelines/BDDNC 4.     AAN Brain Death/Death by Neurologic Criteria Checklist – https://www.aan.com/Guidelines/Home/GetGuidelineContent/1101 5.     Kirschen, M. P., Lewis, A., & Greer, D. M. (2024). The 2023 American Academy of Neurology, American Academy of Pediatrics, Child Neurology Society, and Society of Critical Care Medicine Pediatric and Adult Brain Death/Death by Neurologic Criteria Determination Consensus Guidelines: What the Critical Care Team Needs to Know. Critical care medicine, 52(3), 376–386. https://doi.org/10.1097/CCM.0000000000006099 6.     Greer, D. M., Shemie, S. D., Lewis, A., Torrance, S., Varelas, P., Goldenberg, F. D., Bernat, J. L., Souter, M., Topcuoglu, M. A., Alexandrov, A. W., Baldisseri, M., Bleck, T., Citerio, G., Dawson, R., Hoppe, A., Jacobe, S., Manara, A., Nakagawa, T. A., Pope, T. M., Silvester, W., … Sung, G. (2020). Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA, 324(11), 1078–1097. https://doi.org/10.1001/jama.2020.11586 7.     Lele, A. V., Brooks, A., Miyagawa, L. A., Tesfalem, A., Lundgren, K., Cano, R. E., Ferro-Gonzalez, N., Wongelemegist, Y., Abdullahi, A., Christianson, J. T., Huong, J. S., Nash, P. L., Wang, W. Y., Fong, C. T., Theard, M. A., Wahlster, S., Jannotta, G. E., & Vavilala, M. S. (2023). Caseworker Cultural Mediator Involvement in Neurocritical Care for Patients and Families With Non-English Language Preference: A Quality Improvement Project. Cureus, 15(4), e37687. https://doi.org/10.7759/cureus.37687 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

This podcast details the role, training, and experience of three pharmacists who work in clinical research. The guests discuss clinical research pharmacy practice at institutional, industry, and federal levels and share advice for pharmacists and pharmacy students who want to start a career in clinical research. This podcast is hosted by Michaela L. Myerson, Pharm.D., who at the time of recording, is a PGY-2 Investigational Drugs and Research resident.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Welcome to the fifth episode of our “Citation Classics” series for Shoulder and elbow! In this episode, our team covers the most cited articles on Medial Elbow Instability. Watch on YouTube: https://youtu.be/Q9gtM2ILmRQ  Link to post: https://naileditortho.com/mei/  Click here for show notes The goal of these episodes is to go over the most cited articles in a certain topic over the past 15-20 years to give learners an idea of what articles are being read and what are some of the important studies out there to read! In this episode we have Dr. Samuel Fuller, a PGY-1 resident at University at Buffalo, Dr. Alexander Macfarlane, a PGY-5 resident at University at Buffalo, Teja Polisetty, a PGY-1 at Harvard University, Matthew Corsi, a 3rd year medical student at Wayne State University School of Medicine, and Jalen Warren, a 3rd year medical student at Ohio University College of Health Sciences. Enjoy!

A 70 year old healthy female is referred to you with a 5.7 cm abdominal aortic aneurysm. As an astute clinician you are aware that current guidelines support surgical repair for her AAA. What if there was new data to suggest this patient may not benefit from repair? What would be the optimal size threshold that she would benefit from AAA repair? Tune into this episode of Behind the Knife, where the vascular surgery subspecialty team discusses a paper that challenges current size threshold guidelines for AAA repair.  Hosts:  Dr. Bobby Beaulieu is an Assistant Professor of Vascular Surgery at the University of Michigan and the Program Director of the Integrated Vascular Surgery Residency Program as well as the Vascular Surgery Fellowship Program at the University of Michigan. Dr. Frank Davis is an Assistant Professor of Vascular Surgery at the University of Michigan Dr. Drew Braet is a PGY-5 Integrated Vascular Surgery Resident at the University of Michigan Learning Objectives - Review the current size threshold guidelines for surgical repair of abdominal aortic aneurysms - Understand the limitations of the aforementioned guidelines - Understand the methodology, findings, limitations, and clinical applications of the manuscript “Size thresholds for repair of abdominal aortic aneurysms warrant reconsideration.” References 1.    Columbo JA, Scali ST, Jacobs BN, et al. Size thresholds for repair of abdominal aortic aneurysms warrant reconsideration. Journal of Vascular Surgery. 2024;79(5):1069-1078.e8. doi:10.1016/j.jvs.2024.01.017 https://pubmed.ncbi.nlm.nih.gov/38262565/ 2.    Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. Journal of Vascular Surgery. 2018;67(1):2-77.e2. doi:10.1016/j.jvs.2017.10.044 https://pubmed.ncbi.nlm.nih.gov/29268916/ 3.    Wanhainen A, Van Herzeele I, Bastos Goncalves F, et al. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. European Journal of Vascular and Endovascular Surgery. 2024;67(2):192-331. doi:10.1016/j.ejvs.2023.11.002 https://pubmed.ncbi.nlm.nih.gov/38307694/ 4.    The UK Small Aneurysm Trial Participants, Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms.  Lancet 1998;352 (9141) 1649- 1655 https://pubmed.ncbi.nlm.nih.gov/9853436/ 5.    Lederle  FAWilson  SEJohnson  GR  et al. Aneurysm Detection and Management Veterans Affairs Cooperative Study Group, Immediate repair compared with surveillance of small abdominal aortic aneurysms.  N Engl J Med 2002;346 (19) 1437- 1444 https://pubmed.ncbi.nlm.nih.gov/12000813/ 6.    United Kingdom EVAR Trial Investigators; Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med. 2010 May 20;362(20):1872-80. doi: 10.1056/NEJMoa0911056. Epub 2010 Apr 11. PMID: 20382982. https://pubmed.ncbi.nlm.nih.gov/20382982/ 7.    Lederle FA, Johnson GR, Wilson SE, Ballard DJ, Jordan WD Jr, Blebea J, Littooy FN, Freischlag JA, Bandyk D, Rapp JH, Salam AA; Veterans Affairs Cooperative Study #417 Investigators. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA. 2002 Jun 12;287(22):2968-72. doi: 10.1001/jama.287.22.2968. PMID: 12052126. 8.    Lancaster EM, Gologorsky R, Hull MM, Okuhn S, Solomon MD, Avins AL, Adams JL, Chang RW. The natural history of large abdominal aortic aneurysms in patients without timely repair. J Vasc Surg. 2022 Jan;75(1):109-117. doi: 10.1016/j.jvs.2021.07.125. Epub 2021 Jul 26. PMID: 34324972. https://pubmed.ncbi.nlm.nih.gov/34324972/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

VTE prophylaxis is more than just some squeezy leg socks and a one-size fits all dose of enoxaparin!  Ever wonder how VTE prophylaxis is similar to constipation?  Have you or a loved one been hurt by a hospital administrator telling you that VTE is a never event?  Come with us, and our special guest Dr. Bryan Cotton, on this journey to the frontier of research attempting to debunk this myth and improve patient care by reducing VTE rates in trauma patients.   Hosts: - Michael Cobler-Lichter, MD, PGY4/R2: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @mdcobler (X/twitter) - Eva Urrechaga, MD, PGY-8, Vascular Surgery Fellow University of Pennsylvania Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center General Surgery Residency @urrechisme (X/twitter) - Eugenia Kwon, MD, Trauma/Surgical Critical Care Attending: Loma Linda University Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center Trauma/CC Fellowship - Brandon Parker, DO, Assistant Professor of Surgery, 5 years in practice University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @BrandonParkerDO (X/twitter) - Bryan Cotton, MD, MPH, FACS, Professor of Surgery, 20 years in practice  University of Texas Health Science Center at Houston/Red Duke Trauma Institute at Memorial Herman Hospital @bryanacotton1 (X/twitter) Learning Objectives: - Describe the rationale for the addition of aspirin to chemoprophylactic regimens for VTE -  Identify appropriate screening systems for trauma patients at high risk for VTE -  Describe the rationale for monitoring anti factor Xa levels in the trauma population receiving VTE chemoprophylaxis - List the major conclusions of the two studies discussed regarding the addition of aspirin to VTE chemoprophylaxis regimens in trauma patients, and the change in antithrombin activity levels over time in relation to enoxaparin responsiveness in polytrauma patients Quick Hits: 1.     On adjusted analysis, the standard VTE PPX plus aspirin group had a lower OR of developing VTE, though limitations of this study highlight need for future prospective work 2.     Trauma patients often suffer from decreased activity of antithrombin 3, which may mediate the relatively higher rates of VTE in this population. 3.     Trauma patients who went on to develop VTE were more likely to not achieve satisfactory anti Xa levels, with a VTE rate of 30% in the never-responder group, the group for which Xa levels were never higher than 0.2 4.     Ex vivo supplementation of antithrombin seems to improve enoxaparin responsiveness.  Remember, enoxaparin and heparin are HELPING AT3, not the other way around References 1.     Lammers D, Scerbo M, Davidson A, et al. Addition of aspirin to venous thromboembolism chemoprophylaxis safely decreases venous thromboembolism rates in trauma patients. Trauma Surg Acute Care Open. 2023;8(1):e001140. doi:10.1136/tsaco-2023-001140 https://pubmed.ncbi.nlm.nih.gov/37936904/ 2.     Vincent LE, Talanker MM, Butler DD, et al. Association of Changes in Antithrombin Activity Over Time With Responsiveness to Enoxaparin Prophylaxis and Risk of Trauma-Related Venous Thromboembolism. JAMA Surg. 2022;157(8):713-721. doi:10.1001/jamasurg.2022.2214 https://pubmed.ncbi.nlm.nih.gov/35731524/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Marking the first episode in our PGY playlist, guest hosts Lindsay Hampson (UCSF) and Gina Badalato (Columbia) speak with Onyi Ibeziako, a third-year resident at UT Southwestern, about effectively handling challenges during the early years of urology residency. --- SYNPOSIS Dr. Ibeziako offers practical advice on managing competing responsibilities, building relationships with hospital staff, and developing early surgical skills. She offers valuable personal insights on self-directed study, triage of tasks, and making the most of these valuable years to set up for a successful career ahead. --- TIMESTAMPS 00:00 - Introduction 05:43 - Early Residency Challenges 10:51 - Relationships with Nursing 14:23 - Multitasking 24:06 - Developing Surgical Skills as an Intern 33:09 - Continuous Learning and Final Pearls of Wisdom

Welcome to the fourth episode of our “Citation Classics” series for Shoulder and elbow! In this episode, our team covers the most cited articles on Rotator Cuff Tears. Watch on YouTube: https://youtu.be/HH2cbv9CYaY  Link to post: https://naileditortho.com/rct/  Click here for show notes The goal of these episodes is to go over the most cited articles in a certain topic over the past 15-20 years to give learners an idea of what articles are being read and what are some of the important studies out there to read! In this episode we have Dr. Samuel Fuller, a PGY-1 resident at University at Buffalo, Dr. Alexander Macfarlane, a PGY-5 resident at University at Buffalo, Teja Polisetty, a PGY-1 at Harvard University, Matthew Corsi, a 3rd year medical student at Wayne State University School of Medicine, and Jalen Warren, a 3rd year medical student at Ohio University College of Health Sciences. Enjoy!

Join the Behind the Knife Surgical Oncology Team as we discuss the presentation, work-up, and management of gastric cancer. Hosts: - Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center - Connor Chick, MD (@connor_chick) is a Surgical Oncology fellow at Ohio State University. - Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a PGY-6 General Surgery resident at Brooke Army Medical Center - Beth (Elizabeth) Carpenter, MD (@elizcarpenter16) is a PGY-5 General Surgery resident at Brooke Army Medical Center Learning Objectives: In this episode, we review the basics of gastric cancer, including presentation, work-up, staging, and treatment modalities as well as high yield topics including the Siewert classification system. We also briefly discuss trials establishing peri-operative chemotherapy regimens for gastric cancer and the controversy of D1 vs. D2 lymphadenectomy. Links to Papers Referenced in this Episode Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. NEJM 2006 Jul;355(1):11-20. https://www.nejm.org/doi/full/10.1056/NEJMoa055531 Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesphageal junction adenocarcinoma (FLOT4): a randomized, phase2/3 trial Lancet 2019 May;393(10184):1948-1957. https://pubmed.ncbi.nlm.nih.gov/30982686/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

The old CEO is the new CEO at the athletic brand, but can he turn the ship around? (00:21) Jason Hall and Deidre Woollard discuss: - Why Kevin Plank is back in the CEO seat at Under Armour. - What makes Dick's Sporting Goods so resilient. - The making of a perfect storm for homebuilders. (15:42) Bill Mann talks to Pagaya CEO Gal Krubiner about using AI to change the world of fintech. Companies discussed: LEN, PGY, DKS, UA, UAA Host: Deidre Woollard Guests: Gal Krubiner, Bill Mann, Jason Hall Producer: Ricky Mulvey Engineers: Kyle Carruthers, Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Behind the Knife the vascular surgery subspecialty team discusses a few case scenarios of patients with dialysis associated hand ischemia (or steal syndrome). Although a rare, steal syndrome can be detrimental to patients with end stage renal disease and result in not only risk of losing dialysis access but even their limb.  What options do you have to fix this problem? In this episode, we will cover the who is at risk of this, and what options you have to fix it. Hosts:  Dr. Bobby Beaulieu is an Assistant Professor of Vascular Surgery at the University of Michigan and the Program Director of the Integrated Vascular Surgery Residency Program as well as the Vascular Surgery Fellowship Program at the University of Michigan. Dr. David Schectman is a Vascular Surgery Fellow at the University of Michigan Dr. Drew Braet is a PGY-4 Integrated Vascular Surgery Resident at the University of Michigan Learning Objectives - Review high-yield topics regarding hemodialysis access - Understand the incidence of and the relevant risk factors for dialysis associated steal syndrome - Review the spectrum of presenting symptoms and relevant workup for dialysis associated steal syndrome - Understand surgical treatment options for dialysis associated steal syndrome References Please review the journal article below for helpful pictures and depictions of the operations we describe in this episode. - Al Shakarchi J, et al. Surgical techniques for haemodialysis access-induced distal ischaemia. J Vasc Access. 2016 Jan-Feb;17(1):40-6. https://pubmed.ncbi.nlm.nih.gov/26349875/ Other helpful references - Kordzadeh A, Parsa AD. A Systematic review of distal revascularization and interval ligation for the treatment of vascular access-induced ischemia. J Vasc Surg 2019; 70:1364. https://pubmed.ncbi.nlm.nih.gov/31153703/ - Huber TS, Larive B, Imprey PB, et al. Access-related hand ischemia and the Hemodialysis Fistula Maturation Study. J Vasc Surg 2016;64:1050. https://pubmed.ncbi.nlm.nih.gov/27478007/ - Sidawy An, Spergel LM, Besarab A, et al. The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008; 48:2S. https://pubmed.ncbi.nlm.nih.gov/19000589/ ***Fellowship Application - https://forms.gle/5fbYJ1JXv3ijpgCq9*** Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen